Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma

BACKGROUND: In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus emerged in China and quickly spread into a worldwide pandemic. Prior to the development of specific drug therapies or a vaccine, more immediately available treatments were sought including convalescent p...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandeberg, Peter, Cruz, Maria, Diez, Jose Maria, Merritt, W. Keither, Santos, Benjamin, Trukawinski, Susan, Wellhouse, Andrea, Jose, Marta, Willis, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251388/
https://www.ncbi.nlm.nih.gov/pubmed/33715160
http://dx.doi.org/10.1111/trf.16378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251388/
https://www.ncbi.nlm.nih.gov/pubmed/33715160
http://dx.doi.org/10.1111/trf.16378

Ejemplares similares